We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+0.22%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.3B
AUM Growth
-$33M
Cap. Flow
+$38.3M
Cap. Flow %
0.2%
Top 10 Hldgs %
20.28%
Holding
1,369
New
102
Increased
385
Reduced
639
Closed
72

Sector Composition

Rank Sector Weight
1 Technology 22.13%
2 Healthcare 11.9%
3 Financials 11.8%
4 Consumer Discretionary 9.38%
5 Industrials 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIVO
1351
DELISTED
Meridian Bioscience Inc
VIVO
-18,320
Closed -$406K
EAR
1352
DELISTED
Eargo, Inc. Common Stock
EAR
-2,992
Closed -$2.39M
FTVIU
1353
DELISTED
FinTech Acquisition Corp. VI Units
FTVIU
-20,000
Closed -$201K
AAQC.U
1354
DELISTED
Accelerate Acquisition Corp Units
AAQC.U
-16,395
Closed -$165K
OEPWU
1355
DELISTED
One Equity Partners Open Water I Corp. Unit
OEPWU
$0 ﹤0.01%
2
-35,437
-100% -$352K
FVT.U
1356
DELISTED
Fortress Value Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fifth of one Warrant
FVT.U
$0 ﹤0.01%
+51
New +$509
GGPIU
1357
DELISTED
Gores Guggenheim, Inc. Unit
GGPIU
-67,119
Closed -$672K
APSG.U
1358
DELISTED
Apollo Strategic Growth Capital Units, each consisting of one Class A Ordinary Share and one-third W
APSG.U
$0 ﹤0.01%
+1
New +$10
SPAQ
1359
DELISTED
Spartan Acquisition Corp. III
SPAQ
-47,183
Closed -$461K
SPAQ.U
1360
DELISTED
Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo
SPAQ.U
-34,785
Closed -$349K
DRNA
1361
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-12,575
Closed -$469K
ATMR.U
1362
DELISTED
Altimar Acquisition Corp II Units
ATMR.U
-20,000
Closed -$200K
YAC
1363
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
-50,208
Closed -$495K
CLDR
1364
DELISTED
Cloudera, Inc.
CLDR
-15,640
Closed -$247K
CORE
1365
DELISTED
Core Mark Holding Co., Inc.
CORE
-545,883
Closed -$24.6M
MXIM
1366
DELISTED
Maxim Integrated Products
MXIM
-2,887
Closed -$303K
ALXN
1367
DELISTED
Alexion Pharmaceuticals
ALXN
-10,236
Closed -$1.88M
MBAC.U
1368
DELISTED
M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
MBAC.U
-5,586
Closed -$56K
ATAQ.U
1369
DELISTED
Altimar Acquisition Corp III Units
ATAQ.U
$0 ﹤0.01%
2
-35,852
-100% -$358K

Similar funds

Glenmede Trust's Q3 2021 Portfolio in Review

As of Q3 2021, Glenmede Trust held 1,369 positions worth $19.3B, down 0.17% from $19.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Glenmede Trust's Q3 2021 filing shows 102 new, 385 increased, 639 reduced and 72 closed positions. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 5,864,565 shares worth $152M. The largest sale was Johnson & Johnson, an estimated $31.8M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 5,864,565 shares worth $152M.
  • Glenmede Trust added most to Twitter, Inc. in Q3 2021, an estimated $40.2M increase.
  • Glenmede Trust's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $31.8M.
  • Glenmede Trust fully exited Core Mark Holding Co., Inc. in Q3 2021, selling an estimated $24.6M.
  • Glenmede Trust's ten largest holdings make up 20% of its $19.3B portfolio in Q3 2021.
  • Glenmede Trust opened 102 new positions and closed 72 in Q3 2021.
  • Glenmede Trust's portfolio value fell 0.17% quarter-over-quarter to $19.3B.

Based on Glenmede Trust's 13F filing for Q3 2021, filed 15 Nov 2021.